Loren Walensky, M.D., Ph.D, Dana-Farber Cancer Institute (IMAGE)

Dana-Farber Cancer Institute

Loren Walensky, M.D., Ph.D, Dana-Farber Cancer Institute

Caption

Loren Walensky, M.D., Ph.D, and colleagues have developed an anti-cancer peptide that overcomes the stubborn resistance to chemotherapy and radiation often encountered in relapsed and refractory blood cancers, which are difficult to cure because their cells deploy strong protein "deflector shields" to neutralize the cell death signals that chemotherapy agents used against them initially.

Credit

Sam Ogden

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.